|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/7088 |
| (11) | Number of the document | 2152879 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08749943.0 |
| Date of filing the European patent application | 2008-04-30 | |
| (97) | Date of publication of the European application | 2010-02-17 |
| (45) | Date of publication and mention of the grant of the patent | 2012-11-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2008/055365 |
| Date | 2008-04-30 |
| (87) | Number | WO 2008/132234 |
| Date | 2008-11-06 |
| (30) | Number | Date | Country code |
| 915371 P | 2007-05-01 | US | |
| 23244 | 2008-01-24 | US |
| (72) |
WORM, Jesper, DK
|
| (73) |
Santaris Pharma A/S,
Fremtidsvej 3, 2970 H rsholm,
DK
|
| (54) | RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF BETA-CATENIN |
| RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF BETA-CATENIN |